Table 1 Cohort characteristics. Per trial arm characteristics are provided in Additional file 1: Table S1
Characteristics | Entire cohort | Taxane-treated | Non-taxane |
|---|---|---|---|
N = 4900 | N = 2535 | N = 2365 | |
Age | |||
 > 65 | 2150 | 1012 | 1138 |
 ≤ 65 | 2750 | 1523 | 1227 |
Sex | |||
 Male | 2746 | 1068 | 1678 |
 Female | 2154 | 1467 | 687 |
Prior chemotherapy | |||
 Naive | 4240 | 2368 | 1872 |
 Excluding taxanes | 167 | 167 | 0 |
 Any | 493 | 0 | 493 |
BSA m2 median [quartiles] | 1.84 [1.69–1.98] | 1.81[1.67–1.96] | 1.88 [1.73–2.03] |
Prev. diabetes diagnosis | 743 | 362 | 381 |
Chemotherapy received | |||
 Taxane and platinum | 2035 | 2035 | 0 |
 Platinum only | 626 | 0 | 626 |
 Taxane only | 500 | 500 | 0 |
 None | 1739 | 0 | 1739 |
PN events | 1117 | 1002 | 115 |
 Grade 1 | 709 | 634 | 75 |
 Grade  ≥ 2 | 408 | 368 | 40 |